Shanghai Pharmaceuticals
Scope
Date
~
-
Bio & Pharma
FDA to review Hanmi Pharmaceutical’s Rolontis for marketing approval
The US Food and Drug Administration has begun reviewing a medicine developed by South Korea’s Hanmi Pharmaceutical Co. for marketing authoriza...
Apr 13, 2022 (Gmt+09:00)
-
Alternative investments
E-Land sells Shanghai warehouse for $2.2 bn to lower debt ratio
Retail conglomerate E-Land Group completed selling its first overseas logistics center in Shanghai for about 1.4 billion Chinese yuan ($2.2 billion)...
Jan 12, 2022 (Gmt+09:00)
language -
Bio
K-bio's out-licensing this year reaches $9.3 bn
Overseas technology transfers from South Korean biotechs and pharmaceutical manufacturers this year have exceeded 11 trillion won ($9.3 billion), al...
Nov 18, 2021 (Gmt+09:00)
language -
Biotech
Korea’s bio startup Voronoi inks $324 million deal with Brickell Biotech
Voronoi Inc., a South Korean biotechnology startup, has clinched a $324 million deal to grant Brickell Biotech, a US clinical-stage pharmaceutical f...
Sep 02, 2021 (Gmt+09:00)
language -
Pharmaceuticals
Daewoong Pharmaceutical aims to top $4 bn in sales by 2027
South Korea-based Daewoong Pharmaceutical Co. is hoping to achieve 5 trillion won ($4.4 billion) in sales by 2027, meaning that the company aims to ...
Aug 04, 2021 (Gmt+09:00)
language -
Electric vehicles
Hyundai debuts First Genesis EV sedan at Shanghai Auto Show
Hyundai Motor Co. on Monday unveiled an electric version of its premium brand Genesis at the opening of Auto Shanghai 2021 as the top South Korean c...
Apr 19, 2021 (Gmt+09:00)
language